Given the importance of the CXCL16/CXCR6 axis in leukocyte trafficking, it may emerge as a druggable target to attenuate lung immune cell infiltration and prevent COPD development and progression. The gene discussed is CXCL16; the disease is chronic obstructive pulmonary disease.